Aleksandra Boldys

Katowice, SL 40752, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure.

Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure.

Journal: International journal of molecular sciences

Published: January 30, 2026

Impact of Short-Term Liraglutide Therapy on Non-Invasive Markers of Liver Fibrosis in Patients with MASLD.

Impact of Short-Term Liraglutide Therapy on Non-Invasive Markers of Liver Fibrosis in Patients with MASLD.

Journal: Metabolites

Published: June 22, 2025

Liraglutide Reduces Liver Steatosis and Improves Metabolic Indices in Obese Patients Without Diabetes: A 3-Month Prospective Study.

Liraglutide Reduces Liver Steatosis and Improves Metabolic Indices in Obese Patients Without Diabetes: A 3-Month Prospective Study.

Journal: International journal of molecular sciences

Published: May 30, 2025

Liraglutide Therapy in Obese Patients Alters Macrophage Phenotype and Decreases Their Tumor Necrosis Factor Alpha Release and Oxidative Stress Markers-A Pilot Study.

Liraglutide Therapy in Obese Patients Alters Macrophage Phenotype and Decreases Their Tumor Necrosis Factor Alpha Release and Oxidative Stress Markers-A Pilot Study.

Journal: Metabolites

Published: September 20, 2024

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy.

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy.

Journal: International journal of molecular sciences

Published: June 28, 2024

The impact of glucagon and exenatide on oxidative stress levels and antioxidative enzyme expression in in vitro induced steatosis in HepG2 cell culture.

The impact of glucagon and exenatide on oxidative stress levels and antioxidative enzyme expression in in vitro induced steatosis in HepG2 cell culture.

Journal: Endokrynologia Polska

Published: March 20, 2024

Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.

Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.

Journal: World journal of gastroenterology

Published: December 28, 2023

Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.

Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: August 31, 2023

Inclisiran-A Revolutionary Addition to a Cholesterol-Lowering Therapy.

Inclisiran-A Revolutionary Addition to a Cholesterol-Lowering Therapy.

Journal: International journal of molecular sciences

Published: February 28, 2023

Exenatide prevents statin-related LDL receptor increase and improves insulin secretion in pancreatic beta cells (1.1E7) in a protein kinase A-dependent manner.

Exenatide prevents statin-related LDL receptor increase and improves insulin secretion in pancreatic beta cells (1.1E7) in a protein kinase A-dependent manner.

Journal: Journal of applied biomedicine

Published: May 31, 2022

Insight into the Evolving Role of PCSK9.

Insight into the Evolving Role of PCSK9.

Journal: Metabolites

Published: February 12, 2022

Endocrine diseases as causes of secondary hyperlipidemia.

Endocrine diseases as causes of secondary hyperlipidemia.

Journal: Endokrynologia Polska

Published: July 22, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026